First Generic Of Gilead’s Biktarvy In India Debuts

Hetero launches cut-price version of Gilead’s Biktarvy in India but 20 other India-based firms also hold licenses for the product. Gilead is entitled to a “modest royalty” on products produced under the voluntary license.

HIV virus
First India Launch Of Generic Biktarvy • Source: Shutterstock

Hetero Drugs Ltd. has introduced a cut-price generic version of Gilead Sciences Inc.’s HIV therapy Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg tablets) in India, the first such version to hit the market under a broad licensing deal provided by the US firm to a large group of local firms.

Gilead told Scrip that it had provided rights to Hetero under a voluntary license to produce generic versions of Biktarvy...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip